Mahkam Zanganeh

Mahkam Zanganeh is a declared insider at 2 companies; the most frequent names are Summit Therapeutics Inc. and Pulse Biosciences, Inc. Over a trading history stretching from 6 December 2022 to 21 October 2025, the count stands at 29 filings.

The open-market record is one-sided, with 13 purchases worth €52.8M and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 12 share grants and 3 option exercises. 2025 to date brings 3 purchases and no sales.

A typical purchase (the median) is worth €431k. Of 12 purchases, 12 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 23 October 2025: a share grant of €225.9M, in Summit Therapeutics Inc. The last insider purchase was made public on 23 October 2025, 366 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.